Blue Bell, PA, United States of America

Alexander I Kuklin


Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2002-2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Insights into Inventor Alexander I. Kuklin

Introduction

Alexander I. Kuklin, a notable inventor based in Blue Bell, Pennsylvania, has made significant contributions in the field of RNA analysis. With a focus on advancing chromatography methods, he holds two patents that reflect his innovative approach to scientific challenges.

Latest Patents

Kuklin's latest patents focus on a Matched Ion Polynucleotide Chromatography method designed for the size-based segregation of RNA molecules. This method involves applying a mixture of RNA to a polymeric separation medium with non-polar surfaces, utilizing a mobile phase that includes a counterion reagent and an organic component. This technique is particularly effective for segregating RNA molecules ranging from 100 to 20,000 nucleotides in length. Additionally, another patent of his outlines the use of a reverse phase column containing polymeric beads for RNA analysis, which also emphasizes the importance of denaturing conditions during elution for improved segregation.

Career Highlights

Kuklin's professional journey includes his role at Transgenomic, Inc., where he has been able to apply his innovative ideas in an environment focused on genetic analysis solutions. His patents indicate a deep understanding of polymeric materials and their application in medical and research settings.

Collaborations

Throughout his career, Kuklin has collaborated with esteemed colleagues such as Douglas T. Gjerde and David P. Hornby. These partnerships have fostered a rich collaborative atmosphere, enabling the sharing of ideas and pushing the boundaries of RNA analysis technology.

Conclusion

Alexander I. Kuklin stands out as an influential inventor in the domain of RNA analysis. His patented methodologies not only demonstrate his expertise but also contribute significantly to advancements in genetic research. His continued work at Transgenomic, Inc. showcases the impact of innovation in biotechnology and the importance of collaboration among professionals in advancing scientific understanding.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…